Keyword: «sanctions»

The article examines the historical aspects of the development of the pharmaceutical indus-try in Russia, the economic features of the development and production of pharmaceutical substances and medicines, as well as the problems faced by the industry with the beginning of sanctions restrictions. The author evaluates the state import substitution programs, the purpose of which is to reduce dependence on the import of medicines and pharmaceutical substances to Russia. The dynamics of the pharmaceutical market growth, as well as the dynamics of the decrease in the import of medicines from foreign countries are analyzed. Based on the analysis, conclusions were drawn about the failure to achieve the targets stated in state programs and the continued dependence on imported medicines. However, we can note a positive trend of increasing funding for research in the pharmaceutical industry, and the creation of own samples of medicines is also proceeding at an accelerated pace.

In connection with the sanctions conditions, Russia is turning to the East, which has a positive effect on Russian-Chinese trade and economic cooperation. Russia's focus on import substitution must be gradually reduced and its industries developed, which is what our country's policy is aimed at. Under the current conditions, it is difficult to immediately solve this problem, which is why Russia is focused on import substitution from China.